Freshly isolated human chondrocytes exhibit a natural, biologically relevant phenotype during in vitro expansion SAN ANTONIO, TX – Investigators exploring chondrocytes in vitro have the ability to study a more biologically-relevant phenotype with CELLvo™ Human Articular Chondrocytes from StemBioSys. Isolated from healthy donors, CELLvo™ Chondrocytes are available to scientists before being cultured at passage 0, or […]
Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes Supports global efforts to develop therapeutics, diagnostic assay components and vaccines to combat the COVID-19 Coronavirus pandemic Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene […]
Merck and The Jenner Institute today announced that the Jenner Institute has laid the foundation for large-scale production of its COVID-19 vaccine candidate, ChAdOx1 nCoV-19. DARMSTADT, GERMANY Recently developed manufacturing platform allows large-scale manufacturing Joint team reduced process development time to two months from a year – a critical step to manufacturing COVID-19 vaccine at […]
MGI has announced a major upgrade for DNBSEQ-G50 with improvements to flexibility, turnaround time and performance. The original FC (Flow Cell) with 300M total reads is upgraded to FCL (Flow Cell Large) with 500M total reads, and a new FCS (Flow Cell Small) has been released with total reads of 100M. In addition, a longer […]
Bournemouth, UK and Newark, CA, USA – Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS™ single cell cloning instrument. Leap-In Transposases enable stable high titer clones to be isolated whilst screening orders of magnitude fewer […]
Carlsbad, CA – On February 26, 2020, Active Motif announced the successful isolation of antibodies from patients in China recovering from 2019 Coronavirus related pneumonia (COVID-19). The full suite of antibodies is now available for research as well as commercial applications. “The discovery and expression of a full human antibody against the COVID-19 virus is […]
Columbia, Missouri, USA and Utrecht, the Netherlands Harry S. Truman Memorial Veterans’ Hospital’s research program is nationally recognized, in part, because of its Biomolecular Imaging Center (BIC). Using the latest imaging technology, researchers at Truman VA’s BIC conduct preclinical and translational studies to improve the lives of Veterans and all Americans through health care discovery […]
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the […]
Synthesizing 768 oligos just got faster with Dr. Oligo 768XLc The Dr. Oligo 768XLc high throughput oligo synthesizer is Biolyticʻs fastest synthesizer yet FREMONT, California – Biolytic Lab Performance Inc. unveiled its novel oligo synthesizer, the Dr. Oligo 768XLc, the most commercially advanced platform for high throughput nucleic acid synthesis. Designed to be operated […]
New structure to enhance company’s focus on customers, disruptive innovation, and growth; Chief operating officer to drive operational excellence CORNING, N.Y. — Corning Incorporated announced on Wednesday that it is reorganizing its operating structure based on extensive analysis and leadership review. The new structure aligns executive management and business teams around five Market-Access Platforms (MAPs): […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
